The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStar Energy Regulatory News (STAR)

Share Price Information for Star Energy (STAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.90 (8.145%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 11.50
STAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loans from Directors and Grant of Warrants

25 Mar 2020 07:00

RNS Number : 4697H
Starcom PLC
25 March 2020
 

25 March 2020

 

 

Starcom Plc

("Starcom" or the "Company")

 

 

Loans from Directors and Employee

and Grant of Warrants

 

Starcom (AIM: STAR), which specialises in the development of wireless, Internet-Of-Things (IoT) based solutions for the remote tracking, monitoring and protection of a variety of assets, announces that the Company has, on 24 March 2020 entered into loan agreements (the "Loan Agreements") with certain directors and an employee of the Company (the "Lenders"), pursuant to which they have provided loans to the Company totalling approximately £243,600 (the "Loans"). Under the terms of the Loan Agreements, the Lenders have also been issued warrants (the "Warrants") to subscribe for ordinary shares in the Company ("Ordinary Shares").

 

Background to and reasons for the Loans

 

Although it is too early to predict what the full impact of the global Covid-19 pandemic will be on the Company and its operations, the Board is pleased to report that to date the Company has remained under pressure from customers to fulfil existing orders and continue supply of its products. Since the majority of the Company's products are utilised in the movement of cargo rather than people, activity has remained at a high level. There has however been some delay in the fulfilment of certain orders by the Company as a result of international restrictions being imposed on the Company and its own suppliers. The Company has taken the necessary measures to ensure that it can continue to operate effectively whilst keeping its staff safe.

 

Given the current uncertainty caused as a result of the Covid-19 pandemic, the Board of the Company considers that it is prudent to strengthen the Company's balance sheet at this time through the entry into the Loans. Further, the provision of the Loans by certain directors demonstrates the Board's confidence in the business despite the global economic turbulence.

 

Details of the Loans

 

The Company has entered into the Loan Agreements with the following parties:

 

 Lender

Value of Loan provided

Number of Warrants granted

Montrose Securities Limited, a company controlled by Michael Rosenberg

(Non-Executive Chairman)

£100,000

1,600,000

Avi Engel

(Non-Executive Director)

429,330 Israeli Shekels

(approximately £100,000)

1,600,000

Igor Vatenmacher

(Chief Financial Officer)

100,000 Israeli Shekels (approximately £21,800)

400,000

Starcom Employee

100,000 Israeli Shekels (approximately £21,800)

400,000

 

Under the terms of the Loan Agreements, interest is payable on the principal Loan amount at a rate of 8 per cent. per annum payable quarterly in arrears and the Loan principal is repayable on 30 September 2021. Each of the Loans are convertible into new Ordinary Shares, at the sole discretion of the Lender, at a conversion price of 1.25p per Ordinary Share (being a premium of 25% to the closing mid-market share price on 24 March 2020) at any time up until the Loan repayment date. In addition, the Loans can be repaid early at the election of the Company, although not before 30 September 2020, with an early redemption fee of 8% of the principal Loan amount.

 

Of the Loan proceeds, NIS 165,453 (approximately £39,000) will be used to satisfy a historic outstanding debt owed to Avi Engel in respect of past fees. The remainder of the Loan proceeds will be used to fund the growth in inventory as needed to meet anticipated sales orders, as well as for the continued development of the Company's sales and distribution infrastructure and for general working capital purposes.

 

Under the Loan Agreements, Avi Hartman, CEO, is providing a personal guarantee to the Lenders against 50% of the principal Loan value.

 

The Warrants 

 

Pursuant to the Loan Agreements, the Company has granted 4,000,000 Warrants to subscribe for Ordinary Shares to the Lenders, as set out in the table above.

 

The Warrants are exercisable at a price of 1.5p pence per Ordinary Share, being a premium of 50% to the closing mid-market share price on 24 March 2020. The Warrants are exercisable from the date of grant and expire on the second anniversary of the grant. Following the grant of the Warrants, the Company has 53,293,947 options and warrants to subscribe for Ordinary Shares in issue, representing 15.4% of the Company's current issued share capital.

 

The FCA notifications, made in accordance with the requirements of the EU Market Abuse Regulation, are appended below.

 

Related Party Transactions

 

The entering into the Loan Agreements with directors of the Company being, Avi Engel and Igor Vatenmacher, as well as a company controlled by Michael Rosenberg, and the associated grant of Warrants, constitute related party transactions under rule 13 of the AIM Rules for Companies. The director of the Company independent of these transactions, being Martin Blair, considers, having consulted with the Company's Nominated Adviser, that the terms of the Loan Agreements and grant of Warrants are fair and reasonable insofar as the Company's shareholders are concerned.

 

 

Enquiries: 

 

Starcom Plc

 

Michael Rosenberg, Chairman

07785 727 595

Avi Hartmann, CEO 

+972 5447 5663

 

 

Allenby Capital Limited (Nominated Adviser and Broker)

020 3328 5656

James Reeve / Jeremy Porter / Asha Chotai

 

 

Peterhouse Capital Limited (Joint Broker)

020 7469 0930

Lucy Williams / Charles Goodfellow / Eran Zucker

 

 

Leander PR (Financial PR)

07795 168 157

Christian Taylor-Wilkinson

 

 

 

 

 1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Rosenberg (Chairman)

Avi Engel (Non-executive Director)

Igor Vatenmacher (Chief Financial Officer)

 

2

Reason for the notification

a)

Position/status

See 1 a) above

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Starcom plc

b)

LEI

213800XVU7WF3QMF4826

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 Identification code

Warrants to subscribe for Ordinary Shares of no par value

 

Identification code (ISIN) for Starcom plc ordinary shares: JE00B8WSDY21

b)

Nature of the transaction

Grant of warrants to subscribe for ordinary shares in the Company

 

c)

Price(s) and volume(s)

Director/PDMR

 Price(s)

Volume(s)

Michael Rosenberg

Exercisable at 1.5p

1,600,000

Avi Engel

Exercisable at 1.5p

1,600,000

Igor Vatenmacher

Exercisable at 1.5p

400,000

 

d)

Aggregated information

- Aggregated volume

- Price

Price(s)

Volume(s)

1.5p

2,775,000

 

e)

Date of the transaction

24 March 2020

 

f)

Place of the transaction

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSEMEFLESSEDD
Date   Source Headline
4th Jul 201912:23 pmRNSUpdate Re Auditor
28th Jun 20195:00 pmRNSTotal Voting Rights
20th Jun 20191:00 pmRNSDirector Shareholding
17th Jun 20192:45 pmRNSResult of AGM
17th Jun 20197:00 amRNSAGM Statement
3rd Jun 201911:13 amRNSUpdate on North African Distributor
31st May 20191:39 pmRNSNotice of AGM and Proposed Grant of Options
24th May 20197:49 amRNSDirectorate Change
30th Apr 20195:00 pmRNSTotal Voting Rights
18th Apr 201911:00 amRNSPrice Monitoring Extension
18th Apr 20197:00 amRNSIssue of Equity
5th Apr 201912:37 pmRNSLaunch of Lokies
22nd Mar 20197:00 amRNSNew WIMC Agreement
18th Mar 20197:00 amRNSFinal Results
26th Feb 201910:44 amRNSLaunch of Electric Motorcycle
7th Feb 20197:00 amRNSXplosive Agreement
31st Jan 20197:00 amRNSAppointment of CFO and Change of Nominated Adviser
29th Jan 20197:00 amRNSTrading Update
17th Jan 20192:45 pmRNSHolding(s) in Company
16th Jan 20193:45 pmRNSDirector Declaration
11th Jan 20197:00 amRNSBusiness Update
5th Dec 20187:00 amRNSNominated Adviser Status
30th Nov 201811:17 amRNSTotal Voting Rights
7th Nov 20187:00 amRNSDistribution Agreement and Placing
29th Aug 20187:00 amRNSInterim Results
30th Jul 20187:00 amRNSTrading Update
2nd Jul 20187:00 amRNSTotal Voting Rights
26th Jun 201810:04 amRNSBlock listing six monthly return
31st May 201812:40 pmRNSTotal Voting Rights
23rd May 201812:37 pmRNSPlacing
17th May 20187:00 amRNSLaunch of Watchlock Cube
23rd Apr 20182:02 pmRNSExercise of Warrants and Director Dealing
10th Apr 20187:00 amRNSGrant of options
9th Apr 201811:30 amRNSResult of AGM
9th Apr 20188:25 amRNSAGM Statement
4th Apr 20182:00 pmRNSTotal Voting Rights
22nd Mar 201810:36 amRNSAnnual Report and Notice of AGM
15th Mar 201812:01 pmRNSChange of Registered Office
8th Mar 20187:00 amRNSFinal Results
22nd Feb 201811:24 amRNSHolding(s) in Company
22nd Feb 201811:21 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSTrading Statement
1st Feb 20189:07 amRNSExercise of Warrants
31st Jan 20184:29 pmRNSTotal Voting Rights
29th Jan 201811:21 amRNSHolding(s) in Company
23rd Jan 20187:00 amRNSPlacing
23rd Jan 20187:00 amRNSReplacement: Trading Update
18th Jan 20187:00 amRNSTrading Update
22nd Dec 20177:00 amRNSSenior Management Appointment
30th Oct 20177:00 amRNSPlacing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.